Europe Remote Patient Monitoring (RPM) Market

The Europe remote patient monitoring market is projected to reach USD 11.22 billion by 2030 from USD 6.87 billion in 2025, at a CAGR of 10.3% over the forecast period. Growth in the market is driven by national digital health strategies, expanding virtual wards and hospital-at-home programs, rising chronic disease burden, and pressure on health systems to reduce admissions and costs. Broader reimbursement pilots, stronger MDR-driven trust in certified devices, and the acceleration of cloud, AI, and interoperable platform adoption further enable the scalable, clinically integrated deployment of RPM.

Leading RPM players in Europe are expanding market influence through platform consolidation and evidence-based commercialization. Companies such as Koninklijke Philips N.V., Medtronic, and GE HealthCare are integrating devices, analytics, and provider IT systems to build positions in virtual care workflows. Abbott, Boston Scientific Corporation, and ResMed are using strong clinical and economic validation to unlock reimbursement, accelerate national deployments, and strengthen long-term competitive positioning.

To know about the assumptions considered for the study download the pdf brochure

The prominent players operating in the Europe remote patient monitoring market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden Corporation (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biotronik (Germany), VivaLNK, Inc (US), Teladoc Health, Inc (US), ResMed (US), AliveCor, Inc (US), F. Hoffmann-La Roche Ltd. (Switzerland), iRhythm Inc. (US), Beijing Choice Electronic Tech Co., Ltd. (China), Biotronik (Germany), and Masimo (US).

Koninklijke Philips N.V. (Netherlands) is a global leader of connected care and monitoring solutions, with a commanding presence in virtually all European health systems. The company’s strategy focuses on scaling end-to-end virtual care and hospital-at-home infrastructure. Philips achieves this through deep platform integration, leveraging strengths in enterprise monitoring, cloud interoperability, and clinical workflow digitization. It reinforces its portfolio through targeted partnerships and technology acquisitions that enhance data analytics, telehealth, and device connectivity. This strong vertical integration of its model unites hardware and software with services into one unified RPM ecosystem, embedding the brand throughout European provider networks.

Abbott is a diversified healthcare technology company with a strong footprint across Europe. It holds leading positions in cardiovascular care and diabetes management and diagnostic monitoring. The company prioritizes the development of clinically validated remote monitoring ecosystems. These ecosystems are led by platforms such as Merlin for cardiac care and FreeStyle Libre for glucose management. Abbott continues to invest in sensor innovation, advanced algorithms, and patient engagement capabilities. It extends its market reach through strategic collaborations, digital health partnerships, and targeted acquisitions. Abbott operates a horizontal integration model. This model connects devices, digital platforms, and care management programs to accelerate remote patient monitoring adoption across European healthcare systems.

MARKET RANKING

The leading companies shaping the Europe remote patient monitoring market stand out through clinical depth, device ecosystems, digital workflow integration, and pan-regional scale. Koninklijke Philips N.V. anchors the market with broad patient monitoring and virtual care platforms that integrate connected devices and analytics across radiology and cardiology and acute care settings. Medtronic strengthens the market through its large cardiac monitoring footprint and chronic disease solutions backed by deep ties with European cardiology networks. OMRON Corporation expands access through validated home monitoring devices and connected chronic care programs that support preventive and community-based care models. GE HealthCare drives digital transformation by pairing advanced monitoring systems with data-driven care coordination tools that support hospital-to-home transitions. Abbott advances market maturity through evidence-based cardiac and glucose monitoring ecosystems integrated into provider workflows and national disease management pathways.

Related Reports:

Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com